These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1412350)

  • 21. [Combination of enalapril with diuretics in the treatment of arterial hypertension].
    Alicandri C; Fariello R; Boni E; Zaninelli A; Muiesan G
    Cardiologia; 1986 Oct; 31(10):819-22. PubMed ID: 3028626
    [No Abstract]   [Full Text] [Related]  

  • 22. [What did the ALLHAT study bring? To do the one without foregoing the other].
    MMW Fortschr Med; 2003 Dec; 145(51-52):36-7. PubMed ID: 14974327
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of halving the dosage of atenolol in essential hypertension].
    Brack T; Greminger P; Grüne S; Edmonds D; Vetter W
    Schweiz Med Wochenschr; 1992 May; 122(21):805-10. PubMed ID: 1604286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating mild hypertension.
    Doyle AE
    Aust N Z J Med; 1985 Dec; 15(6):677-8. PubMed ID: 2871829
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antihypertensive therapy: campaign of the giants].
    Füessl HS
    MMW Fortschr Med; 2005 Dec; 147(51-52):28. PubMed ID: 16402700
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications.
    Wikstrand J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S64-75. PubMed ID: 11527139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proven in the practice. Follow up of the use confirms high trial value].
    MMW Fortschr Med; 2003 Dec; 145(51-52):37. PubMed ID: 14974328
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficacy and tolerability of antihypertensive treatment based on atenolol in the prevention of stroke and the regression of left ventricular hypertrophy.
    Cruickshank JM; Higgins TJ; Pennert K; Thorp JM; Zacharias FM; Zacharias FJ
    J Hum Hypertens; 1987 Sep; 1(2):87-93. PubMed ID: 3506623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reserpine versus beta-blocker as an additive to a diuretic in the treatment of Kenyan hypertensives.
    Poulter NR; Sanderson JE
    East Afr Med J; 1986 Jun; 63(6):412-6. PubMed ID: 3769850
    [No Abstract]   [Full Text] [Related]  

  • 30. [Course of hypertension and the potentials for regression].
    Shkhvatsabaia IK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):5-12. PubMed ID: 6212068
    [No Abstract]   [Full Text] [Related]  

  • 31. Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study.
    Reims HM; Kjeldsen SE; Brady WE; Dahlöf B; Devereux RB; Julius S; Beevers G; De Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
    J Hum Hypertens; 2004 Jun; 18(6):381-9. PubMed ID: 15103313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Perindopril: first-line treatment of arterial hypertension].
    Zanchetti A; Desche P
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():63-72. PubMed ID: 2505715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta adrenergic blocking agents to control hypertension in aviation personnel.
    Schamroth CL; Davidoff R; Schamroth JM; Myburgh DP
    Aviat Space Environ Med; 1982 Apr; 53(4):403-4. PubMed ID: 6123307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Uneven sex distribution in the cardiovascular trials--an exaggerated problem].
    Melander H; Rastad JA
    Lakartidningen; 2006 Jun 8-13; 103(23):1856-9. PubMed ID: 16838599
    [No Abstract]   [Full Text] [Related]  

  • 36. Amlodipine or lisinopril was not better than chlorthalidone in lowering CHD risk in hypertension.
    Heckman GA; Psaty BM
    ACP J Club; 2003; 139(3):A15; author reply A15. PubMed ID: 14594435
    [No Abstract]   [Full Text] [Related]  

  • 37. [Can treatment of hypertension prevent myocardial infarction? New controlled clinical trials are proposed].
    Kjeldsen SE; Syvertsen JO; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1993 Feb; 113(6):737-40. PubMed ID: 8096658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of blood pressure and systolic time intervals by diuretics and beta-blockers in essential hypertension.
    González-Gómez A; Gamio Capestany F; Hernández-Cañero A; García-Barreto D
    Cor Vasa; 1983; 25(4):233-40. PubMed ID: 6139268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diuretics in the treatment of arterial hypertension in the aged].
    Castiella Herrero J; Cía Gómez P
    An Med Interna; 1993 Jun; 10(6):303-7. PubMed ID: 8334211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative trial of nifedipine retard and atenolol in the treatment of elderly patients with mild to moderate hypertension.
    Clamp M; Holmes B; Wilcox R
    J Hum Hypertens; 1990 Oct; 4(5):557-63. PubMed ID: 2283646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.